Low Molecular Weight Heparin [EPC]

Known as: LMWH, Low Molecular Weight Heparin, Low Molecular Weight Heparin (LMWH) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
02420142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To evaluate the effects of anticoagulant agent (low-molecular-weight heparin, LMWH) on the pulmonary artery intima… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2016
2016
OBJECTIVE To determine the incidence of deep vein thrombosis (DVT)in patients undergoing spinal surgeries receiving prophylactic… (More)
  • table 1
Is this relevant?
2016
2016
INTRODUCTION Microvesicles including exosomes and microparticles, participate in the placental-maternal crosstalk in normal… (More)
Is this relevant?
2016
2016
Enoxaparin is widely used in clinic, but it has some disadvantages. For example, its anticoagulant activity is weaker compared… (More)
Is this relevant?
2016
2016
OBJECTIVE The objective of the present work was to prepare and evaluate a novel oral formulation for systemic delivery of low… (More)
Is this relevant?
2015
2015
BACKGROUND Venous thromboembolism (VTE) remained common complication following surgical resection of esophageal cancer. In this… (More)
Is this relevant?
2015
2015
OBJECTIVE To evaluate the curative effects and risks of a medical therapy with combined anti-thrombotic agents for thrombosis on… (More)
Is this relevant?
2014
2014
Absorption enhancing effects of chitosan oligomers with different type and varying concentration on the intestinal absorption of… (More)
Is this relevant?